Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity

Cantuti-Castelvetri, Ludovico, Ojha, Ravi, Pedro, Liliana D., Djannatian, Minou, Franz, Jonas, Kuivanen, Suvi, van der Meer, Franziska, Kallio, Katri +21 more·2020·Science
DOI 10.1126/science.abd2985

Cited by (1,003)

Items 201–300 of 1,003

  1. The mechanism underlying extrapulmonary complications of the coronavirus disease 2019 and its therapeutic implication
    Qin Ning, Di Wu, Xiaojing Wang, Dong Xi, Tao Chen, Guang Chen, Hongwu Wang, Huiling Lü, Ming Wang, Lin Zhu et al. · 2022 · Signal Transduction and Targeted Therapy
  2. Evaluating the impact of COVID-19 on male reproduction
    Yu Tian, Liquan Zhou · 2020 · Reproduction
  3. Strategies to target SARS-CoV-2 entry and infection using dual mechanisms of inhibition by acidification inhibitors
    Chaitra Prabhakara, Rashmi K. Godbole, Parijat Sil, Sowmya Jahnavi, Shah-E-Jahan Gulzar, Thomas S. van Zanten, Dhruv Sheth, Neeraja Subhash, Anchal Chandra, Akshatha Shivaraj et al. · 2021 · PLoS Pathogens
  4. Neurological manifestations of COVID-19: A comprehensive literature review and discussion of mechanisms
    Anton Johansson, Mohamed S. Mohamed, Thiago C. Moulin, Helgi B. Schiöth · 2021 · Journal of Neuroimmunology
  5. Senolytic therapy alleviates physiological human brain aging and COVID-19 neuropathology
    Aguado, Julio, Amarilla, Alberto A., Taherian Fard, Atefeh, Albornoz, Eduardo A., Tyshkovskiy, Alexander, Schwabenland, Marius, Chaggar, Harman K., Modhiran, Naphak, Gómez-Inclán, Cecilia, Javed, Ibrahim et al. · 2023 · Nature Aging
  6. Cytoplasmic short linear motifs in ACE2 and integrin β 3 link SARS-CoV-2 host cell receptors to mediators of endocytosis and autophagy
    Johanna Kliche, Hanna Kuss, Muhammad Ali, Ylva Ivarsson · 2021 · Science Signaling
  7. The SARS-CoV-2 receptor ACE2 is expressed in mouse pericytes but not endothelial cells: Implications for COVID-19 vascular research
    Lars Muhl, Liqun He, Ying Sun, Maarja Andaloussi Mäe, Riikka S. Pietilä, Jianping Liu, Guillem Genové, Lei Zhang, Yuan Xie, Stefanos Leptidis et al. · 2022 · Stem Cell Reports
  8. Tackling COVID-19 with neutralizing monoclonal antibodies
    Corti, Davide, Purcell, Lisa A., Snell, Gyorgy, Veesler, David · 2021 · Cell
  9. Can COVID-19 pandemic boost the epidemic of neurodegenerative diseases?
    Alexei Verkhratsky, Qing Li, Sonia Melino, Gerry Melino, Yufang Shi · 2020 · Biology Direct
  10. Genome-wide CRISPR activation screen identifies candidate receptors for SARS-CoV-2 entry
    Shiyou Zhu, Ying Liu, Zhuo Long Zhou, Zhiying Zhang, Xia Xiao, Zhiheng Liu, Ang Chen, Xiaojing Dong, Feng Tian, Shihua Chen et al. · 2021 · Science China Life Sciences
  11. Mapping of SARS-CoV-2 Brain Invasion and Histopathology in COVID-19 Disease
    Geidy E. Serrano, J. Walkera, R Arce, Michael J. Glass, Daisy Vargas, Lucia I. Sue, Anthony J. Intorcia, Courtney M. Nelson, Javon Oliver, Jacopo Del Papa et al. · 2021 · medRxiv
  12. The Role of Neuropilin-1 (NRP-1) in SARS-CoV-2 Infection: Review
    Monika Gudowska-Sawczuk, Barbara Mroczko · 2021 · Journal of Clinical Medicine
  13. The battle between host and SARS-CoV-2: Innate immunity and viral evasion strategies
    Shilei Zhang, Lulan Wang, Genhong Cheng · 2022 · Molecular Therapy
  14. Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike protein
    Suryadevara, Naveenchandra, Shrihari, Swathi, Gilchuk, Pavlo, VanBlargan, Laura A., Binshtein, Elad, Zost, Seth J., Nargi, Rachel S., Sutton, Rachel E., Winkler, Emma S., Chen, Elaine C. et al. · 2021
  15. SARS-CoV-2 Infection in the Central and Peripheral Nervous System-Associated Morbidities and Their Potential Mechanism
    Mohan Kumar Muthu Karuppan, Dinesh Devadoss, Madhavan G. Nair, Hitendra Singh Chand, Madepalli Krishnappa Lakshmana · 2021 · Molecular Neurobiology
  16. SARS-CoV-2 genomic surveillance identifies naturally occurring truncation of ORF7a that limits immune suppression
    Artem A. Nemudryi, Anna Nemudraia, Tanner Wiegand, Joseph E. Nichols, Deann Teresa Snyder, Jodi F. Hedges, Calvin Cicha, Helen Lee, Karl K. Vanderwood, Diane Bimczok et al. · 2021 · Cell Reports
  17. Multisystemic Cellular Tropism of SARS-CoV-2 in Autopsies of COVID-19 Patients
    Dickson W.L. Wong, Barbara M. Klinkhammer, Sonja Djudjaj, Sophia Villwock, M. Cherelle Timm, Eva Miriam Buhl, Sophie Wucherpfennig, Claudio Cacchi, Till A. Braunschweig, Ruth Knüchel et al. · 2021 · Cells
  18. Regulatory T cells in COVID-19
    Huan Wang, Zhao Wang, Wen Cao, Qianqian Wu, Yujia Yuan, Xiangjian Zhang · 2021 · Aging and Disease
  19. Structure and receptor recognition by the Lassa virus spike complex
    Michael Katz, Jonathan J. Weinstein, Maayan Eilon-Ashkenazy, Katrin Gehring, Hadas Cohen‐Dvashi, Nadav Elad, Sarel Jacob Fleishman, Ron Diskin · 2022 · Nature
  20. SARS-CoV-2 uses CD4 to infect T helper lymphocytes
    Natália Silva Brunetti, Gustavo Gastão Davanzo, Diogo de Moraes, A. Ferrari, Gabriela Fabiano de Souza, Stéfanie Primon Muraro, Thiago L. Knittel, Vinicius de Oliveira Boldrini, Lauar de Brito Monteiro, João Victor Virgílio-da-Silva et al. · 2023 · eLife
  21. Evolution of the SARS-CoV-2 Omicron spike
    Ruth Parsons, Priyamvada Acharya · 2023 · Cell Reports
  22. C-Phycocyanin-derived Phycocyanobilin as a Potential Nutraceutical Approach for Major Neurodegenerative Disorders and COVID-19-induced Damage to the Nervous System
    Pentón-Rol, Giselle, Marín-Prida, Javier, McCarty, Mark F. · 2021 · Current Neuropharmacology
  23. Neurotropism of SARS-CoV-2 and neurological diseases of the central nervous system in COVID-19 patients
    Shobi Veleri · 2021 · Experimental Brain Research
  24. Role of SARS-CoV-2 Spike-Protein-Induced Activation of Microglia and Mast Cells in the Pathogenesis of Neuro-COVID
    Theoharis Constantin Theoharides, Duraisamy Kempuraj · 2023 · Cells
  25. An ACE2 Microbody Containing a Single Immunoglobulin Fc Domain Is a Potent Inhibitor of SARS-CoV-2
    Takuya Tada, Chen Fan, Jennifer Chen, Ramanjit Kaur, Kenneth A. Stapleford, Harry B. Gristick, Belinda M. Dcosta, Craig B. Wilen, Crina M. Nimigean, Nathaniel Roy Landau · 2020 · Cell Reports
  26. COVID-19 Mechanisms in the Human Body—What We Know So Far
    Ashutosh Kumar, Ravi Kant Narayan, Pranav Prasoon, Chiman Kumari, Gurjot Kaur, Santosh Kumar, Maheswari Kulandhasamy, Kishore Sesham, Vikas Pareek, Muneeb A. Faiq et al. · 2021 · Frontiers in Immunology
  27. The P681H Mutation in the Spike Glycoprotein of the Alpha Variant of SARS-CoV-2 Escapes IFITM Restriction and Is Necessary for Type I Interferon Resistance
    María José Lista, Helena Winstone, Harry Wilson, A. Stephens Dyer, Suzanne Pickering, Rui Pedro Galão, Giuditta De Lorenzo, Vanessa M. Cowton, Wilhelm Furnon, Nicolás M. Suárez et al. · 2022 · Journal of Virology
  28. Neurovascular unit, neuroinflammation and neurodegeneration markers in brain disorders
    Duraisamy Kempuraj, Kirk D. Dourvetakis, Jessica Cohen, Daniel Seth Valladares, Rhitik Samir Joshi, Sai Puneeth Kothuru, Tristin Anderson, Baskaran Chinnappan, Amanpreet K. Cheema, Nancy G. Klimas et al. · 2024 · Frontiers in Cellular Neuroscience
  29. SARS-CoV-2 infection in the mouse olfactory system
    Qing Ye, Jia Zhou, Qi He, Rui-Ting Li, Guan Yang, Yao Zhang, Shujia Wu, Qi Chen, Jiahui Shi, Rongrong Zhang et al. · 2021 · Cell Discovery
  30. How integrin phosphorylations regulate cell adhesion and signaling
    Carl Gustav Gahmberg, Mikaela Grönholm · 2021 · Trends in Biochemical Sciences
  31. Multivalent 9-O-Acetylated-sialic acid glycoclusters as potent inhibitors for SARS-CoV-2 infection
    Simon J. L. Petitjean, Wenzhang Chen, Melanie Koehler, Ravikumar Jimmidi, Jinsung Yang, Danahé Mohammed, Blinera Juniku, Megan Lynn Stanifer, Steeve Boulant, Stéphane P. Vincent et al. · 2022 · Nature Communications
  32. The pathogenesis of coronavirus-19 disease
    Alain Borczuk, Rhonda K. Yantiss · 2022 · Journal of Biomedical Science
  33. Integrin activation is an essential component of SARS-CoV-2 infection
    Peter C. Simons, Derek A. Rinaldi, Virginie Bondu, Alison M. Kell, Steven B. Bradfute, Diane S. Lidke, Tione Buranda · 2021 · Scientific Reports
  34. SARS-CoV-2: Emerging Role in the Pathogenesis of Various Thyroid Diseases
    Avaniyapuram Kannan Murugan, Ali Saeed Alzahrani · 2021 · Journal of Inflammation Research
  35. Antidepressant and Antipsychotic Drugs Reduce Viral Infection by SARS-CoV-2 and Fluoxetine Shows Antiviral Activity Against the Novel Variants in vitro
    Senem Merve Fred, Suvi H. Kuivanen, Hasan Uğurlu, Plinio Cabrera Casarotto, Lev Levanov, Kalle Saksela, Olli P. Vapalahti, Eero Ċastrén · 2022 · Frontiers in Pharmacology
  36. Dysregulated Interferon Response and Immune Hyperactivation in Severe COVID-19: Targeting STATs as a Novel Therapeutic Strategy
    Mahdi Eskandarian Boroujeni, Agata Sekrecka, Aleksandra Antonczyk, Sanaz Hassani, Michał Sekrecki, Hanna Nowicka, Natalia Łopacinska, Arta Olya, Katarzyna Kluzek, Joanna Wesoły et al. · 2022 · Frontiers in Immunology
  37. Spike protein mediated membrane fusion during SARS‐CoV‐2 infection
    Xinyu Li, Huijun Yuan, Xiaozhen Li, Hongliang Wang · 2022 · Journal of Medical Virology
  38. SARS-CoV-2 and the spike protein in endotheliopathy
    Luca Perico, Ariela Benigni, Giuseppe Remuzzi · 2023 · Trends in Microbiology
  39. TGF ‐β superfamily co‐receptors in cancer
    John B. Pawlak, Gerard C. Blobe · 2021 · Developmental Dynamics
  40. Neuropilin-1 assists SARS-CoV-2 infection by stimulating the separation of Spike protein S1 and S2
    Zhenlu Li, Matthias Buck · 2021 · Biophysical Journal
  41. Human Defensins Inhibit SARS-CoV-2 Infection by Blocking Viral Entry
    Chuan Xu, Annie Wang, M. Marin, W. Honnen, Santhamani Ramasamy, E. Porter, S. Subbian, A. Pinter, G. Melikyan, Wu-Yuan Lu et al. · 2021 · Viruses
  42. An airway organoid-based screen identifies a role for the HIF1α-glycolysis axis in SARS-CoV-2 infection
    Xiaohua Duan, Xuming Tang, Manoj S. Nair, Tuo Zhang, Yunping Qiu, Wei Zhang, Pengfei Wang, Yaoxing Huang, Jenny Xiang, Hui Wang et al. · 2021 · Cell Reports
  43. Endothelial contribution to COVID-19: an update on mechanisms and therapeutic implications
    Zhangjing Ma, Yi Yang, Yü Huang, Kathy O. Lui · 2021 · Journal of Molecular and Cellular Cardiology
  44. The neurobiology of SARS-CoV-2 infection
    Meinhardt, Jenny, Streit, Simon, Dittmayer, Carsten, Manitius, Regina v., Radbruch, Helena, Heppner, Frank L. · 2024 · Nature Reviews Neuroscience
  45. Molecular basis of cross‐species ACE2 interactions with SARS‐CoV‐2‐like viruses of pangolin origin
    Sheng Niu, Jia Wang, Bin Bai, Lili Wu, Anqi Zheng, Qian Chen, Pei Du, Pengcheng Han, Yanfang Zhang, Yunfei Jia et al. · 2021 · The EMBO Journal
  46. SARS-CoV-2 cell entry beyond the ACE2 receptor
    Shamila D. Alipoor, Mehdi Seyed Mirsaeidi · 2022 · Molecular Biology Reports
  47. The N501Y and K417N mutations in the spike protein of SARS-CoV-2 alter the interactions with both hACE2 and human derived antibody: A Free energy of perturbation study
    Filip Fratev · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  48. Structural Analysis of Neutralizing Epitopes of the SARS-CoV-2 Spike to Guide Therapy and Vaccine Design Strategies
    M. Finkelstein, Adam G. Mermelstein, Emma Parker Miller, P. Seth, Erik-Stephane D. Stancofski, D. Fera · 2021 · Viruses
  49. SARS-CoV-2 Infection of Airway Epithelial Cells
    Gwanghui Ryu, Hyun‐Woo Shin · 2021 · Immune Network
  50. Possible Use of Phytochemicals for Recovery from COVID-19-Induced Anosmia and Ageusia
    幸子 小山, Kenji Kondo, Rumi Ueha, Hideki Kashiwadani, Thomas Heinbockel · 2021 · International Journal of Molecular Sciences
  51. Signaling mechanisms of SARS-CoV-2 Nucleocapsid protein in viral infection, cell death and inflammation
    Wenbiao Wang, Junzhe Chen, Xueqing Yu, Hui-Yao Lan · 2022 · International Journal of Biological Sciences
  52. Encephalitis in Patients with COVID-19: A Systematic Evidence-Based Analysis
    Md Asiful Islam, Cinzia Cavestro, Sayeda Sadia Alam, Shoumik Kundu, Mohammad Amjad Kamal, Faruque Reza · 2022 · Cells
  53. Extracellular vesicles mediate antibody-resistant transmission of SARS-CoV-2
    Bingqing Xia, Xiaoyan Pan, Rong‐Hua Luo, Xurui Shen, Shuangqu Li, Yi Wang, Xiaoli Zuo, Yan Ling Wu, Yingqi Guo, Gengfu Xiao et al. · 2023 · Cell Discovery
  54. Short linear motif candidates in the cell entry system used by SARS-CoV-2 and their potential therapeutic implications
    Bálint Mészáros, Hugo Sámano‐Sánchez, Jesús Alvarado-Valverde, Jelena Čalyševa, Elizabeth Martínez‐Pérez, Renato Alves, Denis C. Shields, Manjeet Kumar, Friedrich Rippmann, Lucia Beatriz Chemes et al. · 2021 · Science Signaling
  55. Extracellular RNA as a Versatile DAMP and Alarm Signal That Influences Leukocyte Recruitment in Inflammation and Infection
    Klaus T. Preissner, Silvia Fischer, Elisabeth Deindl · 2020 · Frontiers in Cell and Developmental Biology
  56. miR-24 Targets the Transmembrane Glycoprotein Neuropilin-1 in Human Brain Microvascular Endothelial Cells
    Pasquale Mone, Jessica Gambardella, Xujun Wang, Stanislovas S. Jankauskas, Alessandro Matarese, Gaetano Santulli · 2021 · Non-Coding RNA
  57. SARS-CoV-2 infects adipose tissue in a fat depot- and viral lineage-dependent manner
    Tatiana D. Saccon, Felippe Mousovich‐Neto, Raissa G. Ludwig, Victor Corasolla Carregari, Ana Beatriz dos Anjos Souza, Amanda Stephane Cruz dos Passos, Matheus Cavalheiro Martini, Priscilla Paschoal Barbosa, Gabriela Fabiano de Souza, Stéfanie Primon Muraro et al. · 2022 · Nature Communications
  58. The establishment of COPD organoids to study host-pathogen interaction reveals enhanced viral fitness of SARS-CoV-2 in bronchi
    Louisa Chan, Danielle E. Anderson, Hong Sheng Cheng, Fransiskus Xaverius Ivan, Si Chen, Adrian Kang Eng Zheng, Randy Foo, Akshamal Mihiranga Gamage, Pei Yee Tiew, Mariko Siyue Koh et al. · 2022 · Nature Communications
  59. Possible routes of SARS‐CoV‐2 invasion in brain: In context of neurological symptoms in COVID‐19 patients
    Ashutosh Kumar, Vikas Pareek, Pranav Prasoon, Muneeb A. Faiq, Pavan Kumar, Chiman Kumari, Ravi Kant Narayan · 2020 · Journal of Neuroscience Research
  60. Potential Role of Antioxidant and Anti-Inflammatory Therapies to Prevent Severe SARS-Cov-2 Complications
    Anna Maria Fratta Pasini, Chiara Stranieri, Luciano Cominacini, Chiara Mozzini · 2021 · Antioxidants
  61. Syndecan receptors: pericellular regulators in development and inflammatory disease
    Sandeep Gopal, Samantha Arokiasamy, Csilla A. Pataki, James R. Whiteford, John Couchman · 2021 · Open Biology
  62. The MEK1/2-inhibitor ATR-002 efficiently blocks SARS-CoV-2 propagation and alleviates pro-inflammatory cytokine/chemokine responses
    André Schreiber, Dorothee Viemann, Jennifer Schöning, Sebastian Schloer, Angeles Mecate‐Zambrano, Linda Brunotte, Aileen Faist, Michael Schöfbänker, Eike Roman Hrincius, Helen Hoffmann et al. · 2022 · Cellular and Molecular Life Sciences
  63. The spike glycoprotein of SARS-CoV-2: A review of how mutations of spike glycoproteins have driven the emergence of variants with high transmissibility and immune escape
    Pedro Filho Noronha Souza, Felipe Pantoja Mesquita, Jackson L. Amaral, Patrícia G.C. Landim, Karollyny Roger Pereira Lima, Marília Braga Costa, Izabelle Rocha Farias, Mônica O. Belém, Yago O. Pinto, H. H. T. Moreira et al. · 2022 · International Journal of Biological Macromolecules
  64. Viral infection and smell loss: The case of COVID‐19
    Isaías Glezer, Alexandre Bruni‐Cardoso, Deborah Schechtman, Bettina Malnic · 2020 · Journal of Neurochemistry
  65. Highly Efficient SARS-CoV-2 Infection of Human Cardiomyocytes: Spike Protein-Mediated Cell Fusion and Its Inhibition
    Chanakha K. Navaratnarajah, David Randall Pease, Peter Halfmann, Biruhalem Taye, Alison J. Barkhymer, Kyle G. Howell, Jon E. Charlesworth, Trace A. Christensen, Yoshihiro Kawaoka, Roberto Cattaneo et al. · 2021 · Journal of Virology
  66. ACE2 is the critical in vivo receptor for SARS-CoV-2 in a novel COVID-19 mouse model with TNF- and IFNγ-driven immunopathology
    Riem Gawish, Philipp M. Starkl, Lisabeth Pimenov, Anastasiya Hladik, Karin Lakovits, Felicitas Oberndorfer, Shane J. Cronin, Anna Ohradanova‐Repic, Gerald Wirnsberger, Benedikt Agerer et al. · 2022 · eLife
  67. Chronological brain lesions after SARS-CoV-2 infection in hACE2-transgenic mice
    Enríc Vidal, Carlos López-Figueroa, Jordi Rodon, Mónica Pérez, Marco Brustolin, Guillermo Cantero, Vı́ctor Guallar, Nuria Izquierdo‐Useros, Jorge Carrillo, Julià Blanco et al. · 2021 · Veterinary Pathology
  68. Severe acute respiratory syndrome coronavirus 2 may be an underappreciated pathogen of the central nervous system
    Syed Benazir Alam, Steven D. Willows, Marianna Kulka, Jagdeep K. Sandhu · 2020 · European Journal of Neurology
  69. More that ACE2? NRP1 may play a central role in the underlying pathophysiological mechanism of olfactory dysfunction in COVID-19 and its association with enhanced survival
    Claire L Hopkins, Jerome Rene Lechien, Sven Saussez · 2020 · Medical Hypotheses
  70. Microglial Implications in SARS-CoV-2 Infection and COVID-19: Lessons From Viral RNA Neurotropism and Possible Relevance to Parkinson’s Disease
    Ifeoluwa Oluleke Awogbindin, Benneth Ben‐Azu, Babatunde Adebiyi Olusola, Elizabeth Toyin Akinluyi, Philip Adeyemi Adeniyi, Thérèse Di Paolo, Marie‐Ève Tremblay · 2021 · Frontiers in Cellular Neuroscience
  71. SARS-CoV-2: Receptor and Co-receptor Tropism Probability
    Narges Eslami, Parisa Shiri Aghbash, Ali Shamekh, Taher Entezari‐Maleki, Javid Sadri Nahand, Abolfazl Jafari-Sales, Hossein Bannazadeh Baghi · 2022 · Current Microbiology
  72. Choosing a cellular model to study SARS-CoV-2
    Gabriel Augusto Pires de Souza, Marion Le Bideau, Céline Boschi, Nathalie Wurtz, Philippe Colson, Sarah Aherfi, Christian Albert Devaux, Bernard La Scola · 2022 · Frontiers in Cellular and Infection Microbiology
  73. SARS-CoV-2 infects human brain organoids causing cell death and loss of synapses that can be rescued by treatment with Sofosbuvir
    Pinar Mesci, Janaína Sena de Souza, Laura Martin‐Sancho, Ángela Macia, Aurian Saleh, Xin Yin, Cedric E. Snethlage, Jason W. Adams, Simoni Helena Avansini, Roberto H. Herai et al. · 2022 · PLoS Biology
  74. The N-terminal domain of spike glycoprotein mediates SARS-CoV-2 infection by associating with L-SIGN and DC-SIGN
    Soh, Wai Tuck, Liu, Yafei, Nakayama, Emi E., Ono, Chikako, Torii, Shiho, Nakagami, Hironori, Matsuura, Yoshiharu, Shioda, Tatsuo, Arase, Hisashi · 2020
  75. Advances in regulating physicochemical properties of mesoporous silica nanocarriers to overcome biological barriers
    Yumei Wang, Kaijun Gou, Xianmou Guo, Jia Ke, Sanming Li, Heran Li · 2021 · Acta Biomaterialia
  76. New Insights Into the Physiopathology of COVID-19: SARS-CoV-2-Associated Gastrointestinal Illness
    Christian Albert Devaux, Jean‐Christophe Lagier, Didier Raoult · 2021 · Frontiers in Medicine
  77. Brain Mechanisms of COVID-19-Sleep Disorders
    Oxana V. Semyachkina-Glushkovskaya, Aysel Mamedova, Valeria Telnova, Maria Klimova, Elena I. Saranceva, Vasily Ageev, Tingting Yu, Dan Yan Zhu, Thomas Penzel, Jürgen Kurths · 2021 · International Journal of Molecular Sciences
  78. The D614G Virus Mutation Enhances Anosmia in COVID-19 Patients: Evidence from a Systematic Review and Meta-analysis of Studies from South Asia
    Christopher S. von Bartheld, Molly M. Hagen, Rafał Butowt · 2021 · ACS Chemical Neuroscience
  79. Mechanisms of COVID-19-induced kidney injury and current pharmacotherapies
    Wissam H. Faour, Ali Choaib, Elio Issa, Francesca El Choueiry, Khodor Shbaklo, Maryline Alhajj, Ramy Touma Sawaya, Zeina Harhous, Eman A. Alefishat, Moni Nader · 2021 · Inflammation Research
  80. SARS‐CoV‐2 and dengue virus co‐infection: Epidemiology, pathogenesis, diagnosis, treatment, and management
    Chowdhury Nusaiba Binte Sayed Prapty, Raad Rahmat, Yusha Araf, Samiha Kamal Shounak, Noor‐A‐Afrin, Tanjim Ishraq Rahaman, Mohammad Jakir Hosen, Chunfu Zheng, Md. Golzar Hossain · 2022 · Reviews in Medical Virology
  81. Infection of lung megakaryocytes and platelets by SARS-CoV-2 anticipate fatal COVID-19
    Aiwei Zhu, Fernando Real, Claude Capron, Arielle R. Rosenberg, Aymeric Silvin, Garett Dunsmore, Jaja Zhu, Andréa Cottignies-Calamarte, Jean‐Marc Massé, Pierre Moine et al. · 2022 · Cellular and Molecular Life Sciences
  82. The COVID-19 pandemic and Alzheimer’s disease: mutual risks and mechanisms
    Feng Chen, Yan‐Ting Chen, Yongxiang Wang, Qiongwei Ke, Lili Cui · 2022 · Translational Neurodegeneration
  83. Amyloid processing in <scp>COVID</scp>‐19‐associated neurological syndromes
    Ziff, Oliver J., Ashton, Nicholas J., Mehta, Puja R., Brown, Rachel, Athauda, Dilan, Heaney, Judith, Heslegrave, Amanda J., Benedet, Andrea Lessa, Blennow, Kaj, Checkley, Anna M. et al. · 2022 · Journal of Neurochemistry
  84. A monoclonal antibody against staphylococcal enterotoxin B superantigen inhibits SARS-CoV-2 entry in vitro
    Mary Hongying Cheng, Rebecca A. Porritt, Magali Noval Rivas, James Krieger, Asli Beyza Ozdemir, Gustavo Garcia, Vaithilingaraja Arumugaswami, Bettina C. Fries, Moshe Arditi, İvet Bahar · 2021 · Structure
  85. Sphingolipids as Modulators of SARS-CoV-2 Infection
    Kid Törnquist, Muhammad Yasir Asghar, Vignesh Srinivasan, Laura Korhonen, Dan Lindholm · 2021 · Frontiers in Cell and Developmental Biology
  86. Eugenol, a Component of Holy Basil (Tulsi) and Common Spice Clove, Inhibits the Interaction Between SARS-CoV-2 Spike S1 and ACE2 to Induce Therapeutic Responses
    Ramesh Kumar Paidi, Malabendu Jana, Sumita Raha, Mary Ashley McKay, Monica Sheinin, Rama K. Mishra, Kalipada Pahan · 2021 · Journal of Neuroimmune Pharmacology
  87. The molecular mechanism of SARS-CoV-2 evading host antiviral innate immunity
    Wenjing Gu, Hui Gan, Yu Ma, Lina Xu, Zhangkai Jason Cheng, Bizhou Li, Xinxing Zhang, Wujun Jiang, Jinlv Sun, Baoqing Sun et al. · 2022 · Virology Journal
  88. WITHDRAWN: SARS-CoV-2 invades cognitive centers of the brain and induces Alzheimer’s-like neuropathology
    Wei‐Bin Shen, Montasir Elahi, James Logue, Penghua Yang, Lauren Baracco, E. Albert Reece, Bingbing Wang, Ling Li, Thomas G. Blanchard, Zhe Han et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  89. SARS-CoV-2 and mitochondrial health: implications of lifestyle and ageing
    Alistair V.W. Nunn, Geoffrey W. Guy, Wolfgang Brysch, Stanley W. Botchway, Wayne D. Frasch, Edward J. Calabrese, Jimmy David Bell · 2020 · Immunity & Ageing
  90. Classical and alternative receptors for SARS‐CoV‐2 therapeutic strategy
    Siti Fathiah Masre, Nurul Farhana Jufri, Farah Wahida Ibrahim, Sayyidi Hamzi Abdul Raub · 2020 · Reviews in Medical Virology
  91. Short linear motif candidates in the cell entry system used by SARS-CoV-2 and their potential therapeutic implications
    Bálint Mészáros, Sámano Sánchez, Hugo, Alvarado Valverde, Jesús, Jelena Čalyševa, Martinez Perez, Elizabeth, Renato Alves, Denis C. Shields, Manjeet Kumar, Friedrich Rippmann, Lucia Beatriz Chemes et al. · 2021 · CONICET Digital (CONICET)
  92. Development and application of therapeutic antibodies against COVID-19
    Lin-jin Ning, H. B. Abagna, Qianhu Jiang, Siqi Liu, Jian Huang · 2021 · International Journal on Biological Sciences
  93. Host cell-intrinsic innate immune recognition of SARS-CoV-2
    Emily A. Madden, Michael S. Diamond · 2021 · Current Opinion in Virology
  94. NRP1 promotes prostate cancer progression via modulating EGFR-dependent AKT pathway activation
    Peng Zhang, Liang Chen, Fenfang Zhou, Zhiwen He, Gang Wang, Yongwen Luo · 2023 · Cell Death and Disease
  95. SARS-CoV-2 ORF8 and SARS-CoV ORF8ab: Genomic Divergence and Functional Convergence
    Sameer Mohammad, Abderrezak Bouchama, Bothina Mohammed Alharbi, Mamoon Rashid, Tanvir Khatlani, Nusaibah S. Gaber, Shuja Shafi Malik · 2020 · Pathogens
  96. Medicinal chemistry strategies towards the development of effective SARS-CoV-2 inhibitors
    Shenghua Gao, Tianguang Huang, Letian Song, Shujing Xu, Yusen Cheng, Srinivasulu Cherukupalli, Dongwei Kang, Tong Zhao, Lin Sun, Jian Zhang et al. · 2021 · Acta Pharmaceutica Sinica B
  97. Multiple Sclerosis and SARS-CoV-2: Has the Interplay Started?
    Gianmarco Bellucci, Virginia Rinaldi, Maria Chiara Buscarinu, Roberta Reniè, Rachele Bigi, Giulia Pellicciari, Emanuele Morena, Carmela Romano, Antonio Marrone, Rosella Mechelli et al. · 2021 · Frontiers in Immunology
  98. Dual inhibition of TMPRSS2 and Cathepsin B prevents SARS-CoV-2 infection in iPS cells
    Rina Hashimoto, Ayaka Sakamoto, Sayaka Deguchi, Renxing Yi, Emi Sano, Akitsu Hotta, Kazutoshi Takahashi, Shinya Yamanaka, Kazuo Takayama · 2021 · Molecular Therapy — Nucleic Acids
  99. Human lungs show limited permissiveness for SARS-CoV-2 due to scarce ACE2 levels but virus-induced expansion of inflammatory macrophages
    Katja Hönzke, Benedikt Obermayer, Christin Mache, Diana Fatykhova, Mirjana Kessler, Simon Dökel, Emanuel Wyler, Morris Baumgardt, Anna Löwa, Karen Hoffmann et al. · 2022 · European Respiratory Journal
  100. Assessing and improving the validity of COVID-19 autopsy studies - A multicentre approach to establish essential standards for immunohistochemical and ultrastructural analyses
    Susanne Krasemann, Carsten Dittmayer, Saskia Freifrau von Stillfried, Jenny Meinhardt, Fabian Heinrich, Kristin Hartmann, Susanne Pfefferle, Edda Thies, Regina von Manitius, Tom Aschman et al. · 2022 · EBioMedicine